Nuvectra Completes 2,000 U.S. Algovita & #194; & #174; SCS System Implantations

PLANO, Texas, July 10, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that the Company’s Algovita® Spinal Cord Stimulation (SCS) system has been implanted in over 2,000 patients in the U.S. The Algovita SCS System utilizes one of the most robust internal pulse generators used for spinal cord stimulation and patent-protected stretchable lead technology to deliver four unique stimulation modes to patients...This story is related to the following:Medical Devices
Source: Industrial Newsroom - Health, Medical and Dental Supplies - Category: Medical Devices Source Type: news